EC Approves Stelara to Treat Adults with Moderately to Severaly Active...
NewsThe EC approval is based on data from three pivotal Phase 3 trials which included approximately 1400 patients with moderately to severely active Crohns disease.
View ArticleEC Approves Stelara to Treat Adults with Moderately to Severely Active...
NewsThe EC approval is based on data from three pivotal Phase 3 trials which included approximately 1400 patients with moderately to severely active Crohns disease.
View ArticleGlobal Crohn's Disease Partnering 2010 to 2016 Prices from USD $1495
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies....
View ArticlePhase 3 Study Results Supporting U.S. FDA and European Commission Approvals...
SPRING HOUSE Pa. Nov. 16 2016 PRNewswire Results from three pivotal Janssen Research & Development LLC Janssensponsored Phase 3 studies published today in The New England Journal of Medicine...
View ArticleCalypso Biotech SA Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCalypso Biotech SA Calypso a spinoff from Merck Serono is a biopharmaceutical company that discovers develops and commercializes antibody therapies. Its pipeline products include CALY0001 a...
View ArticleDeciphera Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances...
SummaryDeciphera Pharmaceuticals LLC Deciphera Pharmaceuticals is a drug research and development company that develops designs and commercializes kinase inhibiting drugs for treating immunological...
View ArticleNatco Pharma Limited NATCOPHARM Pharmaceuticals Healthcare Deals and...
SummaryNatco Pharma Limited Natco Pharma is a pharmaceutical company that focuses on the research development manufacture and commercialization of pharmaceutical substances and finished dosage forms....
View ArticleEnzon Pharmaceuticals Inc. ENZN Pharmaceuticals Healthcare Deals and...
SummaryEnzon Pharmaceuticals Inc. Enzon is a biotechnology company which researches and develops therapeutics for patients with high unmet medical needs. The company's royalty products include...
View ArticleStudy finds arthritis drug significantly effective in treating Crohn's disease
University of California San Diego Researchers at University of California San Diego School of Medicine have shown that ustekinumab a human antibody used to treat arthritis significantly induces...
View ArticleArthritis drug induces response and remission in patients with Crohn's...
Researchers at University of California San Diego School of Medicine have shown that ustekinumab a human antibody used to treat arthritis significantly induces response and remission in patients with...
View ArticleArthritis drug significantly effective in treating Crohn's disease study finds
Ustekinumab a human antibody used to treat arthritis significantly induces response and remission in patients with moderate to severe Crohns disease researchers have shown that.
View ArticleNurse.com Recognizes Five Nurses As 2016 National GEM Award Winners
BROOKFIELD Wis. Nov. 17 2016 PRNewswire Five nurses from around the country have been chosen as national winners in the GEM Giving Excellence Meaning Awards program presented by Nurse.com the premier...
View ArticleImmune Pharmaceuticals Secures Up to $11 Million in New Financing to be...
NEW YORK Nov. 17 2016 PRNewswire Immune Pharmaceuticals NASDAQIMNP Immune announced today that it has secured up to $11 million in new financing from a single family office that is an existing...
View ArticleGlobal Gastrointestinal Partnering 20102016 Deal trends players and...
Global Gastrointestinal Partnering 2010 to 2016 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends...
View ArticleXBiotech Announces Research Collaboration with Renowned Gastroenterologist
XBiotech's True Human antibodies Targeting IL1 alpha IL1alpha to be used in Researching Treatment for Inflammatory Bowel Disease IBD AUSTIN Texas Nov. 17 2016 GLOBE NEWSWIRE XBiotech Inc....
View ArticleDrug Stelara May Ease Crohn's Disease
THURSDAY Nov. 17 2016 People with moderate to severe Crohn's disease who haven't responded to other treatments may benefit from the drug ustekinumab Stelara a new study suggests.Stelara is a monoclonal...
View ArticleNeovacs SA ALNEV Financial and Strategic SWOT Analysis Review Prices from USD...
SummaryNeovacs SA Neovacs a subsidiary of Truffle Capital is a biotechnology company that develops various vaccines. The company offers TNF Kinoid and IFNa Kinoid products used in cure of Rheumatoid...
View ArticleA gastroenterologist sheds light on Crohn's
When Garth Swanson's patients learn they have been diagnosed with Crohn's disease one of the first things they tend to do is seek out others who have it toofriends family members people online.
View ArticleTxCell SA TXCL Financial and Strategic SWOT Analysis Review Prices from USD $300
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells with focus on chronic inflammatory and autoimmune...
View Article